Regulation of autoimmune diabetes by non‐islet‐specific T cells — a role for the glucocorticoid‐induced TNF receptor

Diabetogenic BDC2.5 CD4 T cells induce diabetes when injected into NOD.scid mice. However, when co‐transferred with the OVA‐specific DO11.10 CD4 T cells, BDC2.5 T cells failed to cause diabetes. This inhibition depended upon the stimulation of DO11.10 T cells only with soluble OVA, which skewed their differentiation to a Th2‐type pattern of cytokine secretion in vivo. However, in vivo neutralization of IL‐4, IL‐10 or TGF‐β using monoclonal antibodies did not prevent the inhibition whereas treatment with an antibody against the glucocorticoid‐induced TNF receptor abrogated the protection from disease. In the protected mice, the diabetogenic T cells could be isolated from their spleens and shown to transfer diabetes when injected into new NOD.scid recipients. Thus, the inhibition took place without the physical or functional elimination of the diabetogenic T cells.

[1]  N. Sarvetnick,et al.  Production of interleukin 10 by islet cells accelerates immune-mediated destruction of beta cells in nonobese diabetic mice , 1994, The Journal of experimental medicine.

[2]  D. Godfrey,et al.  α/β–T Cell Receptor (TCR)+CD4−CD8− (NKT) Thymocytes Prevent Insulin-dependent Diabetes Mellitus in Nonobese Diabetic (NOD)/Lt Mice by the Influence of Interleukin (IL)-4 and/or IL-10 , 1998, The Journal of experimental medicine.

[3]  A. Heimberger,et al.  Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. , 1990, Science.

[4]  R. Coffman,et al.  Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell- mediated immunity , 1994, The Journal of experimental medicine.

[5]  E. Shevach Regulatory T cells in autoimmmunity*. , 2000, Annual review of immunology.

[6]  N. Parfrey,et al.  Mechanisms of complete Freund's adjuvant protection against diabetes in BB rats: induction of non-specific suppressor cells. , 1992, Autoimmunity.

[7]  A. Cooke,et al.  The transfer of autoimmune diabetes in NOD mice can be inhibited or accelerated by distinct cell populations present in normal splenocytes taken from young males. , 1990, Journal of autoimmunity.

[8]  L. Wen,et al.  Inhibition of Diabetes by an Insulin-Reactive CD4 T-Cell Clone in the Nonobese Diabetic Mouse , 1997, Diabetes.

[9]  T. Saruta,et al.  Suppression of development of diabetes in NOD mice by lactate dehydrogenase virus infection. , 1992, Journal of autoimmunity.

[10]  A. Cooke,et al.  Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non‐obese diabetic mice , 1999, Parasite immunology.

[11]  O. Lantz,et al.  Overexpression of Natural Killer T Cells Protects Vα14-Jα281 Transgenic Nonobese Diabetic Mice against Diabetes , 1998, The Journal of experimental medicine.

[12]  N. Maclaren,et al.  NKT cells and type-1 diabetes and the "hygiene hypothesis" to explain the rising incidence rates. , 2002, Diabetes technology & therapeutics.

[13]  R. Flavell,et al.  Local expression of TNFalpha in neonatal NOD mice promotes diabetes by enhancing presentation of islet antigens. , 1998, Immunity.

[14]  M. Oldstone Viruses as therapeutic agents. I. Treatment of nonobese insulin- dependent diabetes mice with virus prevents insulin-dependent diabetes mellitus while maintaining general immune competence , 1990, The Journal of experimental medicine.

[15]  P. Morel,et al.  Prevention of diabetes in the NOD mouse by a Th1 clone specific for a hsp60 peptide. , 2000, Journal of autoimmunity.

[16]  M. Kurrer,et al.  Beta cell apoptosis in T cell-mediated autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Flavell,et al.  Transgenic tumor necrosis factor (TNF)-alpha production in pancreatic islets leads to insulitis, not diabetes. Distinct patterns of inflammation in TNF-alpha and TNF-beta transgenic mice. , 1993, Journal of immunology.

[18]  D. Greiner,et al.  Prevention of Diabetes in BB/Wor Rat by Single Transfusion of Spleen Cells: Parameters That Affect Degree of Protection , 1989, Diabetes.

[19]  J. Shimizu,et al.  Stimulation of CD25+CD4+ regulatory T cells through GITR breaks immunological self-tolerance , 2002, Nature Immunology.

[20]  N. Chapman,et al.  Toward Testing the Hypothesis that Group B Coxsackieviruses (CVB) Trigger Insulin-Dependent Diabetes: Inoculating Nonobese Diabetic Mice with CVB Markedly Lowers Diabetes Incidence , 2002, Journal of Virology.

[21]  M. Byrne,et al.  CD4(+)CD25(+) immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. , 2002, Immunity.

[22]  D. Loh,et al.  Differences between responses of naive and activated T cells to anergy induction. , 1998, Journal of immunology.

[23]  A. Cooke,et al.  Cutting Edge: Interactions Through the IL-10 Receptor Regulate Autoimmune Diabetes1 , 2001, The Journal of Immunology.

[24]  M. Sadelain,et al.  Prevention of Type I Diabetes in NOD Mice by Adjuvant Immunotherapy , 1990, Diabetes.

[25]  K. Lafferty,et al.  T-Lymphocyte Clone Specific for Pancreatic Islet Antigen , 1988, Diabetes.

[26]  T. Flotte,et al.  Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[27]  H. Dosch,et al.  Immunological Aspects of Nutritional Diabetes Prevention in NOD Mice: A Pilot Study for the Cow's Milk–Based IDDM Prevention Trial , 1997, Diabetes.

[28]  R. Coffman,et al.  Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. , 1993, International immunology.

[29]  J. Miyazaki,et al.  Suppression of T(h)1 cell activation and prevention of autoimmune diabetes in NOD mice by local expression of viral IL-10. , 2001, International immunology.

[30]  D. Greiner,et al.  Regulatory T cell control of autoimmune destruction of beta cells in the BB rat. , 1988, Advances in experimental medicine and biology.

[31]  A. Baxter,et al.  Comparison of high and low diabetes incidence non-obese diabetic mouse strains , 1989 .

[32]  M. Oldstone Prevention of type I diabetes in nonobese diabetic mice by virus infection. , 1988, Science.

[33]  C. Boitard,et al.  T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice , 1989, The Journal of experimental medicine.

[34]  E. Unanue,et al.  Immune complexes inhibit antimicrobial responses through interleukin-10 production. Effects in severe combined immunodeficient mice during Listeria infection. , 1995, The Journal of clinical investigation.

[35]  P. Pandolfi,et al.  Role of GITR in activation response of T lymphocytes. , 2002, Blood.

[36]  S. Sakaguchi Regulatory T cells , 2000, Cell.

[37]  H. Mcdevitt,et al.  CD4+ T Cells from Glutamic Acid Decarboxylase (GAD)65-specific T Cell Receptor Transgenic Mice Are Not Diabetogenic and Can Delay Diabetes Transfer , 2002, The Journal of experimental medicine.

[38]  C. Benoist,et al.  Damage control, rather than unresponsiveness, effected by protective DX5+ T cells in autoimmune diabetes , 2001, Nature Immunology.

[39]  D. Greiner,et al.  Depletion of RT6.1+ T lymphocytes induces diabetes in resistant biobreeding/Worcester (BB/W) rats , 1987, The Journal of experimental medicine.

[40]  K. Buschard,et al.  Gluten‐free diet prevents diabetes in NOD mice , 1999, Diabetes/metabolism research and reviews.

[41]  Chyung-Ru Wang,et al.  Cd1-Restricted Nk T Cells Protect Nonobese Diabetic Mice from Developing Diabetes , 2001, The Journal of experimental medicine.

[42]  C. Benoist,et al.  Following a diabetogenic T cell from genesis through pathogenesis , 1993, Cell.

[43]  N. Sarvetnick,et al.  Mechanism underlying counterregulation of autoimmune diabetes by IL-4. , 1997, Immunity.

[44]  A. Baxter,et al.  High and low diabetes incidence nonobese diabetic (NOD) mice: origins and characterisation. , 1991, Autoimmunity.

[45]  T. Ohsugi,et al.  Increased incidence of diabetes mellitus in specific pathogen-eliminated offspring produced by embryo transfer in NOD mice with low incidence of the disease. , 1994, Laboratory animal science.

[46]  A. Cooke,et al.  Schistosoma mansoni antigens modulate the activity of the innate immune response and prevent onset of type 1 diabetes , 2003, European journal of immunology.

[47]  J. Miyazaki,et al.  Transgenic expression of IL-10 in pancreatic islet A cells accelerates autoimmune insulitis and diabetes in non-obese diabetic mice. , 1994, International Immunology.

[48]  M. Sadelain,et al.  Complete Freund's adjuvant-induced T cells prevent the development and adoptive transfer of diabetes in nonobese diabetic mice. , 1993, Journal of immunology.

[49]  C. Benoist,et al.  Interferon-gamma impacts at multiple points during the progression of autoimmune diabetes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[50]  Svetlana Ten,et al.  Multiple immuno-regulatory defects in type-1 diabetes. , 2002, The Journal of clinical investigation.

[51]  M. Kurrer,et al.  T Helper 2 (Th2) T Cells Induce Acute Pancreatitis and Diabetes in Immune-compromised Nonobese Diabetic (NOD) Mice , 1997, The Journal of experimental medicine.

[52]  C. Janeway,et al.  Local expression of transgene encoded TNF alpha in islets prevents autoimmune diabetes in nonobese diabetic (NOD) mice by preventing the development of auto-reactive islet-specific T cells , 1996, The Journal of experimental medicine.

[53]  A Jaramillo,et al.  Interleukin 4 reverses T cell proliferative unresponsiveness and prevents the onset of diabetes in nonobese diabetic mice , 1993, The Journal of experimental medicine.

[54]  P. Betts,et al.  Early infection and subsequent insulin dependent diabetes , 1997, Archives of disease in childhood.

[55]  E. Unanue,et al.  A T-cell dormant state in the autoimmune process of nonobese diabetic mice treated with complete Freund's adjuvant. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[56]  A. Baxter,et al.  Comparison of High— and Low—Diabetes-Incidence NOD Mouse Strains , 1989, Diabetes.

[57]  L. Orci,et al.  Expression of a tumor necrosis factor alpha transgene in murine pancreatic beta cells results in severe and permanent insulitis without evolution towards diabetes , 1992, The Journal of experimental medicine.

[58]  J. Lafaille,et al.  The Role of IFN-γ in the Production of Th2 Subpopulations: Implications for Variable Th2-Mediated Pathologies in Autoimmunity1 , 2001, The Journal of Immunology.

[59]  C. Benoist,et al.  Interleukin-4 Deficiency Does Not Exacerbate Disease in NOD Mice , 1998, Diabetes.

[60]  C. Janeway,et al.  Prevention of Diabetes in NOD Mice by Injection of Autoreactive T-Lymphocytes , 1989, Diabetes.

[61]  N. Sarvetnick,et al.  Pancreatic expression of interleukin-4 abrogates insulitis and autoimmune diabetes in nonobese diabetic (NOD) mice , 1996, The Journal of experimental medicine.

[62]  H. Mcdevitt,et al.  Prevention of diabetes in nonobese diabetic mice by tumor necrosis factor (TNF): similarities between TNF-alpha and interleukin 1. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[63]  D. Wegmann,et al.  Peripheral T cell clones from NOD mice specific for GAD65 peptides: lack of islet responsiveness or diabetogenicity. , 1996, Journal of autoimmunity.

[64]  O. Kanagawa,et al.  Regulation of Diabetes Development by Regulatory T Cells in Pancreatic Islet Antigen-Specific TCR Transgenic Nonobese Diabetic Mice1 , 2002, The Journal of Immunology.

[65]  R. Tisch,et al.  Effect of tumor necrosis factor alpha on insulin-dependent diabetes mellitus in NOD mice. I. The early development of autoimmunity and the diabetogenic process , 1994, The Journal of experimental medicine.